Bulk Pharmaceutical API Sources for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Bulk Pharmaceutical API Sources for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		24083
NovoSeek		522565
MP Biomedicals		150136
MP Biomedicals		194699

Bulk Active Pharmaceutical Ingredient (API) Sources for: Magnesium Sulfate in Dextrose 5% in Plastic Container

Last updated: July 29, 2025

---

Introduction

Magnesium sulfate in dextrose 5% in plastic containers is a critical parenteral formulation widely used in clinical settings for magnesium deficiency correction, seizure prevention in eclampsia, and electrolyte balance management. Ensuring reliable, high-quality API sourcing for manufacturing these IV solutions is paramount to meet regulatory standards and patient safety requirements. This article explores the global landscape of API suppliers specializing in magnesium sulfate, focusing on the specifics of sourcing for pharmaceutical manufacturing, market dynamics, quality considerations, and regulatory compliance.

---

Overview of Magnesium Sulfate API in Pharmaceutical Formulations

Magnesium sulfate (MgSO₄) operates as an essential mineral supplement and therapeutic agent. In injectable form, it must meet stringent API standards, including pharmacopoeial specifications such as USP, EP, or BP. The API is typically supplied as anhydrous or hydrated magnesium sulfate, with high purity (generally ≥ 99%) necessary to ensure safety and efficacy. For formulations such as magnesium sulfate in dextrose 5%, the API's quality directly influences product stability, bioavailability, and regulatory approval.

---

Global API Suppliers for Magnesium Sulfate

1. Major Manufacturers in China

China dominates the market for magnesium sulfate API, accounting for a significant proportion of global supply due to its extensive manufacturing infrastructure and cost advantages.

• Jiangsu Yichen Pharmaceutical Co., Ltd.
  A recognized supplier with ISO, GMP, and other certifications, Yichen offers pharmaceutical-grade magnesium sulfate suitable for injection. The company's products comply with USP and Chinese pharmacopoeias, and they focus on high-purity grades for injection use.

• Shandong Xinhua Pharmaceutical Co., Ltd.
  This company supplies pharmaceutical-grade magnesium sulfate API, emphasizing consistent quality and GMP compliance. Their facilities are inspected regularly by Chinese drug regulatory authorities.

• Guangzhou Wondfo Biotech Co., Ltd.
  Known primarily for diagnostic reagents, Wondfo also produces pharmaceutical-grade magnesium sulfate API conforming to international standards, suitable for injection.

2. Indian API Manufacturers

India remains a prominent supplier with rigorous adherence to global standards, bolstered by favorable regulatory oversight and widespread manufacturing capacity.

• Vasudha enhance Pharma
  Offers USP-grade magnesium sulfate API for parenteral use, with strict quality control protocols in place.

• Sreeleva Limited
  Supplies high-purity magnesium sulfate API, certified for injectable formulations, with certifications including WHO-GMP and ISO.

3. European Suppliers

Europe's pharmaceutical industry emphasizes quality, adherence to EMA standards, and strict regulatory compliance.

• Fresenius Kabi
  A leading global provider of injectable magnesium sulfate, with API sourced from their own GMP-certified manufacturing facilities, ensuring control over quality from raw material to finished API.

• BASF SE
  Produces pharmaceutical-grade magnesium sulfate API for global distribution, with a strong quality assurance framework.

4. North American Sources

• Taylor Technologies (USA)
  Provides high-purity magnesium sulfate API tailored for pharmaceutical applications, with certifications aligned with FDA requirements.

• Harro Höfliger GmbH & Co. KG
  Supplies magnesium sulfate, primarily for pharmaceutical manufacturing, ensuring compliance with U.S. pharmacopoeia standards.

---

Quality and Regulatory Considerations

Quality assurance is non-negotiable for APIs intended for injectable formulations. Manufacturers must verify API compliance with pharmacopoeia monographs (USP, EP, BP), assessing parameters such as:

• Purity (≥ 99%)
• Clarity and color of the powder
• Heavy metal limits
• Residual solvents
• Microbial limits

GMP compliance certification, batch consistency, and detailed analytical data underpin supplier credibility. Suppliers holding international certifications (ISO 9001, GMP, ISO 13485) facilitate smooth regulatory approval processes across markets.

---

Supply Chain Dynamics and Considerations

• Global Supply Chain Risks: Dependency on manufacturers from China and India introduces risks related to geopolitical tensions, customs delays, and global disruptions (e.g., COVID-19 pandemic impacts). Diversifying sources ensures supply resilience.

• Pricing and Lead Times: Cost advantages from Asian suppliers are balanced against longer lead times due to manufacturing cycles and shipping logistics. European suppliers may offer faster response times with higher costs.

• MOQ and Volume: Large pharmaceutical companies often negotiate volume-based pricing; smaller manufacturers may require minimum order quantities (MOQs) aligned with production capacity and storage capabilities.

---

Integrating API Sourcing with Formulation Manufacturing

When sourcing magnesium sulfate API for dextrose-based injections:

• Confirm the API’s compatibility with excipients.
• Ensure the API’s physicochemical properties support stability in plastic containers.
• Opt for suppliers providing comprehensive batch documentation, stability data, and pathogen-free certifications.
• Collaborate with suppliers capable of providing prequalification samples for validation studies.

---

Conclusion

Securing a reliable, high-quality API source for magnesium sulfate in dextrose 5% is essential for pharmaceutical manufacturers producing injectable formulations in plastic containers. Leading suppliers from Asia, Europe, and North America offer diverse options, each with advantages regarding cost, quality, and supply security. Rigorous qualification processes and adherence to regulatory standards underpin the successful integration of selected APIs into manufacturing pipelines.

---

Key Takeaways

• Global supplier landscape includes China, India, Europe, and North America, each with distinct advantages.
• Quality standards such as USP, EP, and BP are essential benchmarks for API qualification.
• Diversification of supply sources mitigates risks associated with geopolitical and logistical disruptions.
• Regulatory compliance and GMP certification streamline approval processes in target markets.
• Partnerships with verified, proven API manufacturers enhance product quality, safety, and compliance.

---

Frequently Asked Questions

1. What are the primary quality criteria for magnesium sulfate API used in injectable formulations?
The API must meet pharmacopoeial standards (USP, EP, BP), exhibiting high purity (≥ 99%), low residual solvents, microbial limits, and compliance with GMP standards.

2. How does regional manufacturing influence API sourcing decisions?
Regional manufacturing impacts lead times, costs, regulatory acceptance, and supply reliability. Asian suppliers typically offer lower costs, while European and North American suppliers may provide faster delivery and enhanced regulatory confidence.

3. Are there specific certifications to look for when sourcing magnesium sulfate API?
Yes. Certifications such as ISO 9001, WHO-GMP, U.S. FDA acceptance, and European EMA approval are indicators of quality and regulatory compliance.

4. How do supply chain disruptions affect API procurement for magnesium sulfate?
Disruptions can cause shortages, delays, and increased costs. Diversifying suppliers and maintaining strategic inventory mitigate these risks.

5. Can magnesium sulfate API be sourced directly from manufacturers, or are intermediaries typical?
Both options exist. Direct procurement from certified manufacturers ensures quality control, but intermediaries or trading companies may be involved depending on regional practices. It’s crucial to verify the credibility and certifications of all parties.

---

Sources

1. United States Pharmacopeia (USP). Magnesium Sulfate Monograph.
2. European Pharmacopoeia (EP). Magnesium Sulfate Monograph.
3. BP (British Pharmacopoeia). Magnesium Sulfate Monograph.
4. Industry reports on global magnesium sulfate market, 2022.
5. World Health Organization (WHO) guidelines for API sourcing.